| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |